Pricing Log in Create free account

PMV Pharmaceuticals, Inc. (PMVP) vs vTv Therapeutics Inc. (VTVT)

PMV Pharmaceuticals, Inc. and vTv Therapeutics Inc. are both Biotechnology companies. PMV Pharmaceuticals, Inc. is the larger, with a market value of $96.3M against $86.0M — 1.1× the size. Across the 9 metrics below, vTv Therapeutics Inc. leads on 7 and PMV Pharmaceuticals, Inc. on 2.

Valuation

Metric PMVP VTVT Biotechnology median
P/E n/m n/m 10.26
P/S n/m 7.15 9.18
P/B 0.94 3.44 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.15 n/m 0.65
EV/Sales n/m 4.90 8.98
Earnings yield (112.70%) (3.53%) (34.89%)
Free cash flow yield (105.94%) (6.23%) (24.52%)

Profitability

Metric PMVP VTVT Biotechnology median
Gross margin 0.00% 99.92% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (70.93%) (11.74%) (50.12%)
Return on assets (64.04%) (8.34%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PMVP VTVT Biotechnology median
Revenue growth (TTM) — 654.58% 6.26%
EPS growth (last fiscal year) (29.82%) 0.00% 29.88%
Revenue growth, 5-year CAGR — (39.39%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PMVP VTVT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.70 12.48 4.89
Net debt to EBITDA 1.27 2.71 1.01

Dividend

Metric PMVP VTVT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PMVP VTVT Biotechnology median
Market cap 96.27m 85.96m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack